Singapore Clinical Trial: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of MLC901 (NeuroAiD™II) in subjects with mild to moderate Alzheimer’s Disease (AD).

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the ef... Read More

Clinical Trial: Predicting the Optimal Empirical Antibiotic Therapy for Bacteremia Using an Artificial Intelligence-based Model

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894237) titled 'Predicting the Optimal Empirical Antibiotic Therapy for Bacteremia Using an Artificial Inte... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvalaplin on the Reduction of Major Adverse Cardiovascular Events in Adults with Elevated Lipoprotein(a) Who Have Had a Prior Atherosclerotic Cardiovascular Event or Are at Risk for a First Atherosclerotic Cardiovascular Event – MOVE-Lp(a)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Muvala... Read More

Singapore Clinical Trial: GC-LTFU-001: Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'GC-LTFU-001: Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells'. The fo... Read More

Singapore Clinical Trial: A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Safety of BMN 333 versus Vosoritide in Children with Achondroplasia

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Saf... Read More

Singapore Clinical Trial: A Phase 2 Interventional Study of PF-08634404 in Combination with Chemotherapy in Participants with Previously Untreated Transformed Small Cell Lung Cancer

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Interventional Study of PF-08634404 in Combination with Chemotherapy in Participants wit... Read More

Clinical Trial: Predictors of Success and Failure of v-NOTES Hysterectomy for Large and Very Large Uteri

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895953) titled 'Predictors of Success and Failure of v-NOTES Hysterectomy for Large and Very Large Uteri' o... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves’ Disease Inadequately Controlled With Antithyroid Drugs

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study Evaluating the Efficac... Read More

Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More

Singapore Clinical Trial: A Randomized, Open-Label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with Bevacizumab Compared with Platinum Doublet with Bevacizumab in Participants with Platinum-Sensitive Ovarian Cancer

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with Beva... Read More

• ««
• «
• 3095
• 3096
• 3097
• 3098
• 3099
• 3100
• 3101
• 3102
• 3103
• 3104
• »
• »»